Your email has been successfully added to our mailing list.

×
0 0 0.00230588235294124 -0.00941176470588236 -0.00941176470588236 -0.00941176470588236 -0.0211764705882353 -0.0235294117647058
Stock impact report

Esperion's Q3 Loss Wider Than Expected, Revenues Rise Y/Y [Yahoo! Finance]

Esperion Therapeutics, Inc. (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
Company Research Source: Yahoo! Finance
The company had incurred a loss of 37 cents per share in the year-ago quarter. Esperion generated revenues of $51.6 million, up nearly 52% year over year, driven by higher collaboration revenues and product revenues in the United States. However, the reported figure missed the Zacks Consensus Estimate of $55 million. Shares of Esperion were down in pre-market trading on Nov. 7 owing to the weaker-than-expected results. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. Esperion has two FDA-approved drugs in its commercial portfolio — Nexletol and Nexlizet — that are approved for treating elevated LDL-C (bad cholesterol) and cardiovascular risk reduction. These two oral drugs are marketed as Nilemdo and Nustendi in ex-U.S. markets (excluding Japan, where the company has a collaboration with Otsuka Pharmaceuticals) in partnership with Daiichi Sankyo. The company records royalties on sales of its drugs in ex-U.S. markets. Product revenues, solely from the Show less Read more
Impact Snapshot
Event Time:
ESPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ESPR alerts
Opt-in for
ESPR alerts

from News Quantified
Opt-in for
ESPR alerts

from News Quantified